MILLENNIUM MANAGEMENT LLC - DIAMEDICA THERAPEUTICS INC ownership

DIAMEDICA THERAPEUTICS INC's ticker is DMAC and the CUSIP is 25253X207. A total of 40 filers reported holding DIAMEDICA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
MILLENNIUM MANAGEMENT LLC ownership history of DIAMEDICA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$73,974
-10.9%
28,672
+28.9%
0.00%
Q4 2021$83,000
-9.8%
22,249
+7.5%
0.00%
Q2 2021$92,000
-85.7%
20,690
-70.6%
0.00%
Q1 2021$643,000
+55.3%
70,281
+72.0%
0.00%
Q4 2020$414,000
+1280.0%
40,861
+275.8%
0.00%
Q1 2020$30,000
-81.2%
10,872
-67.0%
0.00%
Q4 2019$160,000
+10.3%
32,963
-53.5%
0.00%
Q3 2019$145,000
-70.6%
70,919
-28.6%
0.00%
-100.0%
Q2 2019$493,00099,3400.00%
Other shareholders
DIAMEDICA THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
JACOB ASSET MANAGEMENT OF NEW YORK LLC 233,730$369,2930.45%
COOPERMAN LEON G 812,508$1,283,8440.08%
CATALYST FINANCIAL PARTNERS LLC 14,475$22,8720.01%
Legend Financial Advisors, Inc. 1,000$1,5800.00%
GEODE CAPITAL MANAGEMENT, LLC 184,870$2920.00%
STATE STREET CORP 133,258$210,5480.00%
MORGAN STANLEY 55,201$87,2230.00%
BlackRock Inc. 69,937$110,5080.00%
Bank of New York Mellon Corp 36,062$56,9820.00%
Citadel Advisors 1,600$2,5280.00%
View complete list of DIAMEDICA THERAPEUTICS INC shareholders